News
INTRODUCING CONCORD BIRTH FLOW: BUILDING THE FUTURE OF CHILD BIRTH
PRESS RELEASE November 8, 2022 St. Antonius Hospital in the Netherlands leading the way with the Concord Birth Flow St. Antonius Hospital is the…
MINDAFFECT SELECTED FOR POLE POSITION PROGRAMME
October 11, 2022 PRESS RELEASE MindAffect selected for Pole Position Programme – DeepTech/Medical field MindAffect, a BCI/AI Healthtech company specializing in the development of…
INTRODUCING CRAINIO: REVOLUTIONISING THE MEASUREMENT OF INTRACRANIAL PRESSURE
PRESS RELEASE October 5, 2022 Crainio, an NLC venture, sets out to revolutionise the measurement of intracranial pressure (ICP) by developing a non-invasive measuring…
INTRODUCING BIODGRAFT: A SOLUTION FOR LIFE
PRESS RELEASE September 27, 2022 BioDGraft, an NLC venture, sets out to eliminate the need for vein harvesting in bypass surgeries, proposing a solution…
INTRODUCING AIDO: BUILDING THE FUTURE PLATFORM FOR INTERVENTIONAL ENDOSCOPY
PRESS RELEASE September 8, 2022 AIDO, an NLC venture, has made it its mission to bring more control to physicians performing endoscopic procedures and…
NLC Collaborates with FFUND and ttopstart to accelerate growth of healthtech ventures
PRESS RELEASE AUGUST 22, 2022 NLC – The European Healthtech Venture Builder, FFUND and ttopstart partner to accelerate the growth of life-saving healthcare ventures…
Haermonics Series A funding offers Pure™ promise for future heart surgery patients
Eindhoven, the Netherlands, August 2, 2022 Haermonics, a clinical-stage breakthrough medtech company, has successfully closed a 4.3 M Series-A financing round with an investment…
Introducing AETHERUS: offering rapid relief to those suffering from breathlessness
PRESS RELEASE July 15, 2022 AETHERUS, an NLC venture, sets out to improve the quality of life of patients suffering from Chronic Obstructive Pulmonary…
Bright times ahead for SuperSeton
PRESS RELEASE May 2022 For the second year in a row, SuperSeton has been selected as one of 29 initiatives to join the EITHealth…
Allergios closes their latest round of seed financing
This spring, the seeds are flying for Allergios Allergios – a biomedical start-up with an innovative allergy test that produces unprecedented accurate results –…
Investment in ARNE helps neonatologists treat newborn babies
PRESS RELEASE April 26, 2022 ARNE B.V. has raised financing from Oost NL and venture builder NLC. ARNE supplies smart software with which neonatologists…
Charles River Laboratories and NLC Collaborate
PRESS RELEASE April 2022 NLC – The European Healthtech Venture Builder and Charles River Laboratories team up to drive drug discovery projects towards finding…